Biomarkers Associated with Vulnerable Atheromatous Plaque

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|19|16|2588-2596

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.19, Iss.16, 2012-06, pp. : 2588-2596

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Matrix Metalloproteinases and Vulnerable Atheromatous Plaque

By  

Current Topics in Medicinal Chemistry, Vol. 12, Iss. 10, 2012-05 ,pp. : 1166-1180

Bentham Science Publishers

Access to resources Recommend Favorite

Vulnerable Plaque Versus Vulnerable Patient: Emerging Blood Biomarkers for Risk Stratification

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 7, Iss. 3, 2007-09 ,pp. : 195-201

Bentham Science Publishers

Access to resources Recommend Favorite

Infections and Atheromatous Plaque: Current Therapeutic Implications

By  

Current Pharmaceutical Design, Vol. 19, Iss. 9, 2013-03 ,pp. : 1638-1650

Bentham Science Publishers

Access to resources Recommend Favorite

Gene Delivery Strategies Targeting Stable Atheromatous Plaque

By  

Current Pharmaceutical Design, Vol. 19, Iss. 9, 2013-03 ,pp. : 1626-1637

Bentham Science Publishers

Access to resources Recommend Favorite

The vulnerable atherosclerotic plaque

By Suckling K.E.  

Expert Opinion on Emerging Drugs, Vol. 3, Iss. 1, 1998-06 ,pp. : 121-134

Informa Healthcare

Access to resources Recommend Favorite